Free Trial

TELA Bio (TELA) Competitors

TELA Bio logo
$1.57 -0.03 (-1.88%)
Closing price 04:00 PM Eastern
Extended Trading
$1.56 -0.01 (-0.32%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TELA vs. SKIN, TLSI, CATX, OM, MGRM, SI, NNOX, STIM, INFU, and INGN

Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Beauty Health (SKIN), TriSalus Life Sciences (TLSI), Perspective Therapeutics (CATX), Outset Medical (OM), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Nano-X Imaging (NNOX), Neuronetics (STIM), InfuSystem (INFU), and Inogen (INGN). These companies are all part of the "medical equipment" industry.

TELA Bio vs. Its Competitors

Beauty Health (NASDAQ:SKIN) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Beauty Health has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

Beauty Health presently has a consensus target price of $2.63, suggesting a potential upside of 14.13%. TELA Bio has a consensus target price of $4.50, suggesting a potential upside of 186.62%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Beauty Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Beauty Health has a net margin of -6.13% compared to TELA Bio's net margin of -54.12%. Beauty Health's return on equity of -32.82% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Beauty Health-6.13% -32.82% -2.96%
TELA Bio -54.12%-329.48%-57.34%

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 94.3% of TELA Bio shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by company insiders. Comparatively, 4.7% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Beauty Health has higher revenue and earnings than TELA Bio. Beauty Health is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beauty Health$334.30M0.87-$29.10M-$0.28-8.21
TELA Bio$75.32M0.83-$37.84M-$1.12-1.40

In the previous week, Beauty Health had 18 more articles in the media than TELA Bio. MarketBeat recorded 18 mentions for Beauty Health and 0 mentions for TELA Bio. Beauty Health's average media sentiment score of 1.08 beat TELA Bio's score of 0.00 indicating that Beauty Health is being referred to more favorably in the media.

Company Overall Sentiment
Beauty Health Positive
TELA Bio Neutral

Summary

Beauty Health beats TELA Bio on 11 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TELA vs. The Competition

MetricTELA BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$62.20M$3.15B$5.76B$10.03B
Dividend YieldN/A2.28%5.28%4.52%
P/E Ratio-1.4021.4575.4326.15
Price / Sales0.83427.65515.98171.98
Price / CashN/A45.5837.2059.76
Price / Book2.189.5911.536.20
Net Income-$37.84M-$53.33M$3.28B$270.56M
7 Day Performance-4.85%0.61%0.42%2.70%
1 Month Performance-8.72%11.09%10.81%8.77%
1 Year Performance-40.53%12.67%61.62%27.50%

TELA Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TELA
TELA Bio
1.7787 of 5 stars
$1.57
-1.9%
$4.50
+186.6%
-41.6%$62.20M$75.32M-1.40120
SKIN
Beauty Health
0.8346 of 5 stars
$2.08
+2.0%
$2.63
+26.2%
+80.7%$263.80M$334.30M-7.431,030Positive News
TLSI
TriSalus Life Sciences
2.3242 of 5 stars
$5.22
+2.2%
$10.75
+105.9%
-1.6%$260.31M$29.43M-4.42106Positive News
CATX
Perspective Therapeutics
1.7818 of 5 stars
$3.36
-0.6%
$12.56
+273.7%
-78.4%$249.52MN/A0.0070
OM
Outset Medical
1.6843 of 5 stars
$13.91
-0.1%
$24.67
+77.3%
+91.7%$247.13M$113.69M-0.69520
MGRM
Monogram Orthopaedics
1.0721 of 5 stars
$5.80
+0.3%
$5.40
-6.9%
+102.5%$235.67M$370K-11.6028Positive News
SI
Shoulder Innovations
3.0834 of 5 stars
$14.92
+0.7%
$19.60
+31.4%
N/A$225.69MN/A-0.5061News Coverage
Analyst Forecast
Quiet Period Expiration
NNOX
Nano-X Imaging
2.5019 of 5 stars
$3.87
-0.3%
$8.50
+119.6%
-33.5%$223.60M$11.28M-4.30190Positive News
STIM
Neuronetics
1.9922 of 5 stars
$3.33
-3.2%
$7.00
+110.2%
+373.1%$220.20M$74.89M-2.95180News Coverage
Positive News
INFU
InfuSystem
3.2706 of 5 stars
$10.78
+0.5%
$12.50
+16.0%
+72.5%$220.19M$139.89M179.70410Positive News
INGN
Inogen
3.8072 of 5 stars
$7.99
+0.4%
$11.00
+37.7%
-24.7%$216.05M$335.70M-7.541,030Positive News

Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners